Anebulo updates on going private: Board to consider sale, merger, or other alternatives

Anebulo Pharmaceuticals, Inc.

Received inbound interest from potential financial and strategic partners after announcing going private on July 23, 2025.
Board will review all strategic alternatives including going private, reverse stock split, asset sale, or merger.
Company plans to hold special stockholder meeting to approve proposed reverse stock split while review continues.
No assurance that process will result in a transaction; no deadline or definitive timetable set.
Even if stockholders approve reverse stock split, Board could abandon it for any reason.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.